Clinical Trial Update: A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update noting safety and drug level assessments for three experimental antibodies (ePGT121v1-LS, PGDM1400LS, and VRC07-523LS) in adults w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PGDM1400LS
• VRC07-523LS
• ePGT121v1-LS

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 1 | Status: RECRUITING